Full Year 2019 Takeda Pharmaceutical Co Ltd Earnings Call Transcript
Thank you, everyone. Thank you for attending Takeda's conference call for the results announcement for fiscal 2018. We just announced the full year results 6 hours ago followed by the web presentation. Then we -- this is the global conference call in English.
I would like to introduce the management team of the management: Mr. Christophe Weber, CEO; and Mr. Andy Plump, President of Research and Development; and Mr. Costa Saroukos, CFO; also Julie Kim, President of Plasma-Derived Therapy Business Unit. So you will be well covered tonight.
So we would like to start with a brief opening remark by Christophe. Please.
Thank you very much for joining. I don't think we have a long presentation right now because we just -- you probably have seen the presentation. So what I suggest is that Costa do -- does a few statements, just summarizing the overall picture,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |